INS CD-CANCER SCREENINGS

This bill updates the Illinois Insurance Code to expand coverage for ovarian cancer screenings. It adds a specific blood test result, high CA-125 levels, to the criteria for being considered at risk for ovarian cancer. The bill also broadens the definition of surveillance tests to include various medical imaging methods and blood tests, rather than just annual screenings.

Supporters of this bill argue that it enhances early detection and diagnosis of ovarian cancer, potentially saving lives by allowing for more comprehensive screening options. They believe that including a broader range of tests will ensure that more women at risk receive the necessary care.

Critics may argue that the bill could lead to unnecessary medical procedures and increased healthcare costs due to the broader range of tests covered. They might also express concern that the inclusion of additional screening methods could result in overdiagnosis and anxiety for patients who may not actually have cancer.